132 related articles for article (PubMed ID: 11124857)
1. Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma.
Rasmuson T; Kristoffersson A; Boquist L
Eur J Endocrinol; 2000 Dec; 143(6):749-54. PubMed ID: 11124857
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
[TBL] [Abstract][Full Text] [Related]
3. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
Newrick PG; Braatvedt GD; Webb AJ; Sheffield E; Corrall RJ
Postgrad Med J; 1994 Mar; 70(821):231-2. PubMed ID: 8183761
[TBL] [Abstract][Full Text] [Related]
4. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
5. Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma.
Betea D; Bradwell AR; Harvey TC; Mead GP; Schmidt-Gayk H; Ghaye B; Daly AF; Beckers A
J Clin Endocrinol Metab; 2004 Jul; 89(7):3413-20. PubMed ID: 15240624
[TBL] [Abstract][Full Text] [Related]
6. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
Tal A; Graves L
South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
[TBL] [Abstract][Full Text] [Related]
7. Metastatic parathyroid carcinoma (mPCa): natural history and treatment of a case.
Vainas IG; Tsilikas C; Grecu A; Pasaitu K; Stergiou I; Kortsaris AH
J Exp Clin Cancer Res; 1997 Dec; 16(4):429-32. PubMed ID: 9505219
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
[TBL] [Abstract][Full Text] [Related]
9. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
10. Minimally symptomatic severe hypercalcaemia in a patient with parathyroid carcinoma.
Sheikh A; Islam N
J Pak Med Assoc; 2006 Jan; 56(1):40-1. PubMed ID: 16454135
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein(50-69) and response to pamidronate therapy for tumour-induced hypercalcaemia.
Dodwell DJ; Abbas SK; Morton AR; Howell A
Eur J Cancer; 1991; 27(12):1629-33. PubMed ID: 1782072
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid carcinoma: Challenges in diagnosis and treatment.
Betea D; Potorac I; Beckers A
Ann Endocrinol (Paris); 2015 May; 76(2):169-77. PubMed ID: 25910997
[TBL] [Abstract][Full Text] [Related]
13. Biochemical effects from treatment with bisphosphonate and surgery in patients with primary hyperparathyroidism.
Jansson S; Morgan E
World J Surg; 2004 Dec; 28(12):1293-7. PubMed ID: 15517486
[TBL] [Abstract][Full Text] [Related]
14. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
15. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
Sims EC; Rogers PB; Besser GM; Plowman PN
Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid carcinoma and oxyphil parathyroid adenoma: an uncommon case of misinterpretation in clinical practice.
Dytz MG; Souza RG; Lázaro AP; Gonçalves MD; Vidal AP; dos Santos Teixeira Pde F; Fleiuss Farias ML
Endocr J; 2013; 60(4):423-9. PubMed ID: 23268928
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia.
Gurney H; Grill V; Martin TJ
Lancet; 1993 Jun; 341(8861):1611-3. PubMed ID: 8099988
[TBL] [Abstract][Full Text] [Related]
18. Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Br J Cancer; 1994 Jul; 70(1):169-72. PubMed ID: 8018531
[TBL] [Abstract][Full Text] [Related]
19. [Surgical therapy concept in primary hyperparathyroidism].
Rusterholz D; Müller W
Schweiz Med Wochenschr Suppl; 2000; 116():62S-65S. PubMed ID: 10780075
[TBL] [Abstract][Full Text] [Related]
20. Oral biphosphonate therapy in metastatic parathyroid carcinoma.
Mann K
Lancet; 1985 Jan; 1(8420):101-2. PubMed ID: 2856997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
